BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8137234)

  • 1. An immunohistochemical study of ras oncoprotein expression in gastric carcinoma.
    Carneiro F; Seruca R; Ribeiro AC; Sobrinho-Simões M
    Cancer; 1994 Apr; 73(7):2010-2. PubMed ID: 8137234
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Spandidos DA
    Anticancer Res; 1989; 9(6):1505-10. PubMed ID: 2697179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of ras oncoprotein expression in gastric carcinoma.
    Teh M; Lee YS
    Cancer; 1993 Sep; 72(6):1846-8. PubMed ID: 8364863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data.
    Kasper HU; Schneider-Stock R; Mellin W; Roessner A
    Int J Oncol; 1998 Jan; 12(1):69-74. PubMed ID: 9454888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells.
    Song JJ; Lee H; Kim E; Kim YS; Yoo NC; Roh JK; Kim BS; Kim J
    Cancer Lett; 2000 Aug; 157(1):1-7. PubMed ID: 10893435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of ras and erbB2 in benign and malignant lesions of the stomach].
    Zhao A; Li J; Lu Y
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):336-9. PubMed ID: 8697969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ras p21 immunohistochemical detection in human endometrial carcinomas.
    Semczuk A; Miturski R; Baranowski W; Jakowicki JA
    Gynecol Obstet Invest; 1997; 44(2):132-5. PubMed ID: 9286729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma.
    Field JK; Yiagnisis M; Spandidos DA; Gosney JR; Papadimitriou K; Vaughan ED; Stell PM
    Eur J Surg Oncol; 1992 Apr; 18(2):168-76. PubMed ID: 1582509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of p21 and p53 expression in gastric cancer.
    Seo YH; Joo YE; Choi SK; Rew JS; Park CS; Kim SJ
    Korean J Intern Med; 2003 Jun; 18(2):98-103. PubMed ID: 12872447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC gene expression in gastric carcinoma: an immunohistochemical study.
    Grace A; Butler D; Gallagher M; Al-Agha R; Xin Y; Leader M; Kay E
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):221-4. PubMed ID: 12373147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
    Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
    J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients.
    Akkiprik M; Celikel CA; Düşünceli F; Sönmez O; Güllüoğlu BM; Sav A; Ozer A
    Turk J Gastroenterol; 2008 Mar; 19(1):22-7. PubMed ID: 18386236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ERas oncogene in gastric carcinoma.
    Kaizaki R; Yashiro M; Shinto O; Yasuda K; Matsuzaki T; Sawada T; Hirakawa K
    Anticancer Res; 2009 Jun; 29(6):2189-93. PubMed ID: 19528480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ras p21 oncoprotein in normal and neoplastic human endometrium.
    Scambia G; Catozzi L; Benedetti-Panici P; Ferrandina G; Battaglia F; Giovannini G; Distefano M; Pellizzola D; Piffanelli A; Mancuso S
    Gynecol Oncol; 1993 Sep; 50(3):339-46. PubMed ID: 8406198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach.
    Oien KA; Vass JK; Downie I; Fullarton G; Keith WN
    Oncogene; 2003 Jul; 22(27):4287-300. PubMed ID: 12833151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells.
    Yashiro M; Yasuda K; Nishii T; Kaizaki R; Sawada T; Ohira M; Hirakawa K
    Int J Oncol; 2009 Nov; 35(5):997-1003. PubMed ID: 19787253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach.
    Honda T; Tamura G; Endoh Y; Nishizuka S; Kawata S; Motoyama T
    Jpn J Clin Oncol; 2005 Oct; 35(10):580-6. PubMed ID: 16254038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of the expression of P21, P53, P185 proteins and the mutation of ras, p53 genes in colorectal adenoma and carcinoma].
    Liang Z; Liu F; Luo Y
    Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):352-5. PubMed ID: 8732090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and mutation of p53 and H-ras genes in the carcinogenesis and development of gastric adenocarcinoma induced by MNNG in rats].
    Meng Z; Lei D; Wang J
    Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):117-9. PubMed ID: 11244961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.